Publication | Closed Access

A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia

Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematologyPhase Iii TrialPharmacotherapyImmunotherapyOncologyRadiation OncologyCancer ResearchHealth Sciences